{"id":504025,"date":"2024-07-19T12:41:37","date_gmt":"2024-07-19T04:41:37","guid":{"rendered":"https:\/\/law.asia\/?p=504025"},"modified":"2024-07-22T12:44:33","modified_gmt":"2024-07-22T04:44:33","slug":"simpson-nishimura-japan-pharma-buyout","status":"publish","type":"post","link":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/","title":{"rendered":"Simpson\u3068\u897f\u6751\u3042\u3055\u3072\u300121\u5104\u7c73\u30c9\u30eb\u306e\u65e5\u672c\u88fd\u85ac\u8cb7\u53ce\u306b\u95a2\u4e0e"},"content":{"rendered":"<p style=\"text-align: justify;\">Simpson Thacher &amp; Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p style=\"text-align: justify;\">\u3053\u306e\u8cb7\u53ce\u3067\u306f\u3001\u30a2\u30b8\u30a2\u3092\u62e0\u70b9\u3068\u3059\u308b\u30d7\u30e9\u30a4\u30d9\u30fc\u30c8\u30a8\u30af\u30a4\u30c6\u30a3\u6cd5\u4ebaMBK\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba\u304c\u3001\u7c73\u56fd\u306e\u540c\u696d\u6cd5\u4eba\u30d6\u30e9\u30c3\u30af\u30b9\u30c8\u30fc\u30f3\u30b0\u30eb\u30fc\u30d7\u304b\u3089\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u3092\u8cb7\u53ce\u3059\u308b\u3082\u306e\u3067\u3001\u30d6\u30e9\u30c3\u30af\u30b9\u30c8\u30fc\u30f3\u306f\u58f2\u5374\u5f8c\u3082\u5c11\u6570\u682a\u3092\u4fdd\u6709\u3057\u307e\u3059\u3002<\/p>\n<p style=\"text-align: justify;\">Simpson Thacher &amp; Bartlett\u306f\u3001\u3053\u306e\u53d6\u5f15\u306b\u304a\u3044\u3066\u3001\u30d6\u30e9\u30c3\u30af\u30b9\u30c8\u30fc\u30f3\u306e\u4ee3\u7406\u4eba\u3092\u52d9\u3081\u3066\u3044\u307e\u3059\u3002\u540c\u4e8b\u52d9\u6240\u306f\u30d6\u30e9\u30c3\u30af\u30b9\u30c8\u30fc\u30f3\u3068\u306e\u9577\u671f\u306b\u308f\u305f\u308b\u53d6\u5f15\u95a2\u4fc2\u304c\u3042\u308a\u3001\u3053\u306e\u30d7\u30e9\u30a4\u30d9\u30fc\u30c8\u30a8\u30af\u30a4\u30c6\u30a3\u306e\u5927\u624b\u304c2021\u5e74\u306b\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u304b\u3089\u30a2\u30ea\u30ca\u30df\u30f3\u3092\u6700\u521d\u306b\u8cb7\u53ce\u3057\u305f\u969b\u306b\u3082\u3001\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p style=\"text-align: justify;\">M&amp;A\u306e\u5c02\u9580\u5bb6\u3067\u3042\u308bAnthony King\u6c0f\u3001Sonya Ho\u6c0f\u3001Paul Kim\u6c0f\u3001Tiffany Shih\u6c0f\u304c\u30c1\u30fc\u30e0\u3092\u7387\u3044\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u306a\u8ca2\u732e\u8005\u3068\u3057\u3066\u3001\u53cd\u30c8\u30e9\u30b9\u30c8\u306e\u5206\u91ce\u306e\u00c9tienne Renaudeau\u6c0f\u3001Sarah Chaudhuri\u6c0f\u3001Luke Cowdell\u6c0f\u3001\u30d0\u30f3\u30ad\u30f3\u30b0\u3068\u30af\u30ec\u30b8\u30c3\u30c8\u5206\u91ce\u306e\u6625\u6210\u771f\u7d00\u5b50\u6c0f\u3001Chenyu Cui\uff08\u5d14 \u8fb0\u5b87\uff09\u6c0f\u3001\u7a0e\u52d9\u5206\u91ce\u306eMeredith Jones\u6c0f\u3001Paul Jansch\u6c0f\u3002\u77e5\u7684\u8ca1\u7523\u5206\u91ce\u306fRon Ben-Yehuda\u6c0f\u304c\u53d6\u308a\u6271\u3044\u3001Steven Klar\u6c0f\u3068Richard Zhang\u6c0f\u304c\u30d5\u30a1\u30f3\u30c9\u306b\u95a2\u308f\u308b\u5c02\u9580\u77e5\u8b58\u3092\u63d0\u4f9b\u3057\u307e\u3057\u305f\u3002\u96c7\u7528\u3068\u798f\u5229\u539a\u751f\u306b\u95a2\u3057\u3066\u306f\u3001Gregory Grogan\u6c0f\u3068Pasco Struhs\u6c0f\u304c\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p style=\"text-align: justify;\">\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001MBK\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba\u306e\u4ee3\u7406\u4eba\u3092\u52d9\u3081\u3066\u3044\u307e\u3059\u3002\u540c\u4e8b\u52d9\u6240\u306e\u30c1\u30fc\u30e0\u306f\u3001M&amp;A\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u5185\u9593\u88d5\u6c0f\u3001\u53e4\u68b6\u9806\u4e5f\u6c0f\u3001\u30cf\u30c9\u30bd\u30f3\u30fb\u30cf\u30df\u30eb\u30c8\u30f3\uff08Hudson Hamilton\uff09\u6c0f\u3001\u30d5\u30a1\u30a4\u30ca\u30f3\u30b9\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u91ce\u4e2d\u654f\u884c\u6c0f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u898f\u5236\u30fb\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u72ac\u585a\u6709\u7406\u6c99\u6c0f\u304c\u7387\u3044\u3066\u3044\u307e\u3059\u3002<\/p>\n<p style=\"text-align: justify;\">\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u30012019\u5e74\u306e\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u306b\u3088\u308bShire\u8cb7\u53ce\u306b\u3082\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u63d0\u4f9b\u3057\u307e\u3057\u305f\u3002<\/p>\n<p style=\"text-align: justify;\">\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u306f\u3001\u4e2d\u56fd\u3001\u97d3\u56fd\u3001\u30bf\u30a4\u3067\u306e\u5e02\u5834\u30d7\u30ec\u30bc\u30f3\u30b9\u3092\u62e1\u5927\u3059\u308b\u8a08\u753b\u3067\u3059\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Simpson Thacher &amp; Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002 \u3053\u306e<\/p>\n","protected":false},"author":13501,"featured_media":503517,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":""},"categories":[8404,8529],"tags":[148401,160643,147167,148407,148400,148406,148402,148404,148405,54011,12401],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"Simpson Thacher &amp; Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simpson\u3068\u897f\u6751\u3042\u3055\u3072\u300121\u5104\u7c73\u30c9\u30eb\u306e\u65e5\u672c\u88fd\u85ac\u8cb7\u53ce\u306b\u95a2\u4e0e\" \/>\n<meta property=\"og:description\" content=\"Simpson Thacher &amp; Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-19T04:41:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-22T04:44:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Website team 05\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/law.asia\/ja\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/law.asia\/ja\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.instagram.com\/law.asia_\/?hl=en\",\"https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/\",\"https:\/\/www.youtube.com\/@Law.asiaLimited\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ja\/#logo\",\"inLanguage\":\"ja\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ja\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/law.asia\/ja\/#website\",\"url\":\"https:\/\/law.asia\/ja\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/law.asia\/ja\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/law.asia\/ja\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ja\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage\",\"inLanguage\":\"ja\",\"url\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg\",\"contentUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg\",\"width\":900,\"height\":600,\"caption\":\"Japan pharma buyout\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage\",\"url\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/\",\"name\":\"Simpson\\u3068\\u897f\\u6751\\u3042\\u3055\\u3072\\u300121\\u5104\\u7c73\\u30c9\\u30eb\\u306e\\u65e5\\u672c\\u88fd\\u85ac\\u8cb7\\u53ce\\u306b\\u95a2\\u4e0e\\uff5cLaw.asia\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ja\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage\"},\"datePublished\":\"2024-07-19T04:41:37+00:00\",\"dateModified\":\"2024-07-22T04:44:33+00:00\",\"description\":\"Simpson Thacher & Bartlett\\u3068\\u897f\\u6751\\u3042\\u3055\\u3072\\u6cd5\\u5f8b\\u4e8b\\u52d9\\u6240\\u306f\\u3001\\u65e5\\u672c\\u306e\\u5927\\u624bOTC\\u533b\\u85ac\\u54c1\\u30e1\\u30fc\\u30ab\\u30fc\\u3067\\u3042\\u308b\\u30a2\\u30ea\\u30ca\\u30df\\u30f3\\u88fd\\u85ac\\u682a\\u5f0f\\u4f1a\\u793e\\u306e3500\\u5104\\u5186\\uff0821\\u5104\\u7c73\\u30c9\\u30eb\\uff09\\u306e\\u8cb7\\u53ce\\u306b\\u95a2\\u3059\\u308b\\u30a2\\u30c9\\u30d0\\u30a4\\u30b9\\u3092\\u884c\\u3063\\u3066\\u3044\\u307e\\u3059\",\"breadcrumb\":{\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage\"},\"author\":{\"@id\":\"https:\/\/law.asia\/ja\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\"},\"headline\":\"Simpson\\u3068\\u897f\\u6751\\u3042\\u3055\\u3072\\u300121\\u5104\\u7c73\\u30c9\\u30eb\\u306e\\u65e5\\u672c\\u88fd\\u85ac\\u8cb7\\u53ce\\u306b\\u95a2\\u4e0e\",\"datePublished\":\"2024-07-19T04:41:37+00:00\",\"dateModified\":\"2024-07-22T04:44:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage\"},\"wordCount\":51,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/law.asia\/ja\/#organization\"},\"image\":{\"@id\":\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg\",\"keywords\":[\"MBK\\u30d1\\u30fc\\u30c8\\u30ca\\u30fc\\u30ba\",\"Nishimura &amp; Asahi\",\"Simpson Thacher &amp; Bartlett\",\"\\u30a2\\u30ea\\u30ca\\u30df\\u30f3\",\"\\u30a2\\u30ea\\u30ca\\u30df\\u30f3\\u88fd\\u85ac\\u682a\\u5f0f\\u4f1a\\u793e\",\"\\u30d7\\u30e9\\u30a4\\u30d9\\u30fc\\u30c8\\u30a8\\u30af\\u30a4\\u30c6\\u30a3\",\"\\u30d6\\u30e9\\u30c3\\u30af\\u30b9\\u30c8\\u30fc\\u30f3\\u30b0\\u30eb\\u30fc\\u30d7\",\"\\u53cd\\u30c8\\u30e9\\u30b9\\u30c8\",\"\\u6b66\\u7530\\u85ac\\u54c1\\u5de5\\u696d\",\"\\u77e5\\u7684\\u8ca1\\u7523\",\"\\u897f\\u6751\\u3042\\u3055\\u3072\\u6cd5\\u5f8b\\u4e8b\\u52d9\\u6240\"],\"articleSection\":[\"Asia Business Law Journal\",\"\\u696d\\u754c\\u30cb\\u30e5\\u30fc\\u30b9\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/law.asia\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/law.asia\/ja\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\",\"name\":\"Website team 05\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/law.asia\/ja\/#personlogo\",\"inLanguage\":\"ja\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g\",\"caption\":\"Website team 05\"},\"url\":\"https:\/\/law.asia\/ja\/author\/johnmanson\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"Simpson Thacher & Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/","og_locale":"ja_JP","og_type":"article","og_title":"Simpson\u3068\u897f\u6751\u3042\u3055\u3072\u300121\u5104\u7c73\u30c9\u30eb\u306e\u65e5\u672c\u88fd\u85ac\u8cb7\u53ce\u306b\u95a2\u4e0e","og_description":"Simpson Thacher & Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059","og_url":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2024-07-19T04:41:37+00:00","article_modified_time":"2024-07-22T04:44:33+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"\u57f7\u7b46\u8005":"Website team 05"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/law.asia\/ja\/#organization","name":"Law.asia","url":"https:\/\/law.asia\/ja\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.instagram.com\/law.asia_\/?hl=en","https:\/\/www.linkedin.com\/company\/asiabusinesslawjournal\/","https:\/\/www.youtube.com\/@Law.asiaLimited","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ja\/#logo","inLanguage":"ja","url":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law.asia\/ja\/#logo"}},{"@type":"WebSite","@id":"https:\/\/law.asia\/ja\/#website","url":"https:\/\/law.asia\/ja\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law.asia\/ja\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.asia\/ja\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ja"},{"@type":"ImageObject","@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage","inLanguage":"ja","url":"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg","width":900,"height":600,"caption":"Japan pharma buyout"},{"@type":"WebPage","@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage","url":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/","name":"Simpson\u3068\u897f\u6751\u3042\u3055\u3072\u300121\u5104\u7c73\u30c9\u30eb\u306e\u65e5\u672c\u88fd\u85ac\u8cb7\u53ce\u306b\u95a2\u4e0e\uff5cLaw.asia","isPartOf":{"@id":"https:\/\/law.asia\/ja\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage"},"datePublished":"2024-07-19T04:41:37+00:00","dateModified":"2024-07-22T04:44:33+00:00","description":"Simpson Thacher & Bartlett\u3068\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240\u306f\u3001\u65e5\u672c\u306e\u5927\u624bOTC\u533b\u85ac\u54c1\u30e1\u30fc\u30ab\u30fc\u3067\u3042\u308b\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e3500\u5104\u5186\uff0821\u5104\u7c73\u30c9\u30eb\uff09\u306e\u8cb7\u53ce\u306b\u95a2\u3059\u308b\u30a2\u30c9\u30d0\u30a4\u30b9\u3092\u884c\u3063\u3066\u3044\u307e\u3059","breadcrumb":{"@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home"}]},{"@type":"NewsArticle","@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#article","isPartOf":{"@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage"},"author":{"@id":"https:\/\/law.asia\/ja\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b"},"headline":"Simpson\u3068\u897f\u6751\u3042\u3055\u3072\u300121\u5104\u7c73\u30c9\u30eb\u306e\u65e5\u672c\u88fd\u85ac\u8cb7\u53ce\u306b\u95a2\u4e0e","datePublished":"2024-07-19T04:41:37+00:00","dateModified":"2024-07-22T04:44:33+00:00","mainEntityOfPage":{"@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#webpage"},"wordCount":51,"commentCount":0,"publisher":{"@id":"https:\/\/law.asia\/ja\/#organization"},"image":{"@id":"https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#primaryimage"},"thumbnailUrl":"https:\/\/law.asia\/wp-content\/uploads\/2024\/07\/Simpson-Nishimura-act-on-USD2.1bn-Japan-pharma-buyout.jpg","keywords":["MBK\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba","Nishimura &amp; Asahi","Simpson Thacher &amp; Bartlett","\u30a2\u30ea\u30ca\u30df\u30f3","\u30a2\u30ea\u30ca\u30df\u30f3\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e","\u30d7\u30e9\u30a4\u30d9\u30fc\u30c8\u30a8\u30af\u30a4\u30c6\u30a3","\u30d6\u30e9\u30c3\u30af\u30b9\u30c8\u30fc\u30f3\u30b0\u30eb\u30fc\u30d7","\u53cd\u30c8\u30e9\u30b9\u30c8","\u6b66\u7530\u85ac\u54c1\u5de5\u696d","\u77e5\u7684\u8ca1\u7523","\u897f\u6751\u3042\u3055\u3072\u6cd5\u5f8b\u4e8b\u52d9\u6240"],"articleSection":["Asia Business Law Journal","\u696d\u754c\u30cb\u30e5\u30fc\u30b9"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law.asia\/ja\/simpson-nishimura-japan-pharma-buyout\/#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/law.asia\/#organization"}},{"@type":"Person","@id":"https:\/\/law.asia\/ja\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b","name":"Website team 05","image":{"@type":"ImageObject","@id":"https:\/\/law.asia\/ja\/#personlogo","inLanguage":"ja","url":"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9aabbf305ce0ba4ee191f1c8271609b1?s=96&d=mm&r=g","caption":"Website team 05"},"url":"https:\/\/law.asia\/ja\/author\/johnmanson\/"}]}},"_links":{"self":[{"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/posts\/504025"}],"collection":[{"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/users\/13501"}],"replies":[{"embeddable":true,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/comments?post=504025"}],"version-history":[{"count":2,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/posts\/504025\/revisions"}],"predecessor-version":[{"id":504053,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/posts\/504025\/revisions\/504053"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/media\/503517"}],"wp:attachment":[{"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/media?parent=504025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/categories?post=504025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law.asia\/ja\/wp-json\/wp\/v2\/tags?post=504025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}